Foresters Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$4.58M Sell
90,300
-17,750
-16% -$834K 0.09% 262
2019
Q2
$4.9M Hold
108,050
0.09% 277
2019
Q1
$5.16M Sell
108,050
-261,200
-71% -$13M 0.09% 279
2018
Q4
$19.2M Buy
369,250
+236,838
+179% +$12.7M 0.36% 93
2018
Q3
$8.22M Buy
+132,412
New +$7.86M 0.13% 221
2018
Q1
Sell
-21,939
Closed -$1.34M 415
2017
Q4
$1.34M Sell
21,939
-623
-3% -$39K 0.02% 340
2017
Q3
$1.44M Sell
22,562
-1,109
-5% -$64.8K 0.02% 326
2017
Q2
$1.32M Buy
+23,671
New +$1.29M 0.02% 324

Other funds holding BMY

Foresters Investment Management's BMY Position: Q3 2019 in Review

Foresters Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2019, selling an estimated $834K and leaving 90,300 shares worth $4.58M. The position accounts for 0.09% of the portfolio, ranked #262.

Foresters Investment Management first reported a position in BMY in Q2 2017 and has held it in 8 quarters since. The position peaked at $19.2M in Q4 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Foresters Investment Management held 90,300 shares of Bristol-Myers Squibb worth $4.58M as of Q3 2019.
  • Foresters Investment Management sold 17,750 Bristol-Myers Squibb shares in Q3 2019, an estimated $834K.
  • Bristol-Myers Squibb made up 0.09% of Foresters Investment Management's portfolio in Q3 2019, its #262 holding.
  • Foresters Investment Management first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 8 quarters since.
  • Foresters Investment Management's Bristol-Myers Squibb position peaked at $19.2M in Q4 2018.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.